These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9626811)

  • 1. TAC-101, a benzoic acid derivative, inhibits liver metastasis of human gastrointestinal cancer and prolongs the life-span.
    Murakami K; Wierzba K; Sano M; Shibata J; Yonekura K; Hashimoto A; Sato K; Yamada Y
    Clin Exp Metastasis; 1998 May; 16(4):323-31. PubMed ID: 9626811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 4-[3,5-bis(trimethylsilyl)benzamido] benzoic acid (TAC-101) on the liver metastasis of colon 26-L5 carcinoma cells.
    Sakukawa R; Murakami K; Ikeda T; Yamada Y; Saiki I
    Oncol Res; 1998; 10(6):287-93. PubMed ID: 9848099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The induction of apoptosis and inhibition of AP-1 activity by TAC-101 (4-[3,5-bis(trimethylsilyl) benzamido] benzoic acid) may result in life prolonging effect in animals bearing metastasizing cancer.
    Shibata J; Murakami K; Aoyagi Y; Oie S; Hashimoto A; Suzuki K; Sano M; Wierzba TT; Yamada Y
    Anticancer Res; 2000; 20(5B):3583-90. PubMed ID: 11131666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-[3,5-Bis(trimethylsilyl)benzamido] benzoic acid (TAC-101) inhibits the intrahepatic spread of hepatocellular carcinoma and prolongs the life-span of tumor-bearing animals.
    Murakami K; Matsuura T; Sano M; Hashimoto A; Yonekura K; Sakukawa R; Yamada Y; Saiki I
    Clin Exp Metastasis; 1998 Oct; 16(7):633-43. PubMed ID: 9932610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer effect of 4-[3,5-bis(trimethylsilyl)benzamido] benzoic acid (TAC-101) against A549 non-small cell lung cancer cell line is related to its anti-invasive activity.
    Shibata J; Murakami K; Wierzba K; Aoyagi Y; Hashimoto A; Sano M; Toko T; Yamada Y
    Anticancer Res; 2000; 20(5A):3169-76. PubMed ID: 11062739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TAC-101 (4-[3,5-bis(trimethylsilyl)benzamido]benzoic acid) inhibits spontaneous mediastinal lymph node metastasis produced by orthotopic implantation of Lewis lung carcinoma.
    Murakami K; Yamaura T; Suda K; Ohie S; Shibata J; Toko T; Yamada Y; Saiki I
    Jpn J Cancer Res; 1999 Nov; 90(11):1254-61. PubMed ID: 10622538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A potential use of a synthetic retinoid TAC-101 as an orally active agent that blocks angiogenesis in liver metastases of human stomach cancer cells.
    Oikawa T; Murakami K; Sano M; Shibata J; Wierzba K; Yamada Y
    Jpn J Cancer Res; 2001 Nov; 92(11):1225-34. PubMed ID: 11714448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of angiogenesis and intrahepatic growth of colon cancer by TAC-101.
    Murakami K; Sakukawa R; Sano M; Hashimoto A; Shibata J; Yamada Y; Saiki I
    Clin Cancer Res; 1999 Sep; 5(9):2304-10. PubMed ID: 10499597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-[3,5-Bis(trimethylsilyl)benzamido] benzoic acid inhibits angiogenesis in colon cancer through reduced expression of vascular endothelial growth factor.
    Minagawa N; Nakayama Y; Inoue Y; Onitsuka K; Katsuki T; Tsurudome Y; Shibao K; Hirata K; Sako T; Nagata N; Ohie S; Kohno K; Itoh H
    Oncol Res; 2004; 14(9):407-14. PubMed ID: 15490972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TAC-101 inhibits intrahepatic metastasis of orthotopically implanted murine hepatocellular carcinoma.
    Lee SJ; Ohashi Y; Sakurai H; Saiki I
    Cancer Lett; 2003 Aug; 198(2):169-77. PubMed ID: 12957355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-[3,5-Bis(trimethylsilyl)benzamido] benzoic acid (TAC-101) induces apoptosis in colon cancer partially through the induction of Fas expression.
    Sako T; Nakayama Y; Minagawa N; Inoue Y; Onitsuka K; Katsuki T; Tsurudome Y; Shibao K; Hirata K; Nagata N; Ohie S; Kohno K; Itoh H
    In Vivo; 2005; 19(1):125-32. PubMed ID: 15796164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel retinoid, 4-[3,5-bis (trimethylsilyl) benzamido] benzoic acid (TAC-101), induces apoptosis of human ovarian carcinoma cells and shows potential as a new antitumor agent for clear cell adenocarcinoma.
    Suzuki N; Aoki D; Oie S; Horiuchi M; Hasegawa Y; Ezawa S; Suzuki A; Susumu N; Hosoi F; Kitazato K; Nozawa S
    Gynecol Oncol; 2004 Sep; 94(3):643-9. PubMed ID: 15350353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of AP-1 interference induced by TAC-101 to tumor growth suppression in a hepatocellular carcinoma model.
    Eshima K; Fukaya S; Sugimoto A; Mori T; Yokoi H; Yamamoto Y; Sugiura S; Honda S; Masuko N; Murakami K; Yamasaki Y; Kagechika H
    Tumour Biol; 2009; 30(1):1-7. PubMed ID: 19142034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemopreventive effect of 4-[3,5-Bis(trimethylsilyl) benzamido] benzoic acid (TAC-101) on MNU-induced colon carcinogenesis in a rat model.
    Nakayama Y; Inoue Y; Minagawa N; Onitsuka K; Nagata J; Shibao K; Hirata K; Sako T; Nagata N; Yamaguchi K
    Anticancer Res; 2009 Jun; 29(6):2059-65. PubMed ID: 19528465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A synthetic retinoid, TAC-101 (4-[3,5-bis (trimethylsilyl) benzamido] benzoic acid), plus cisplatin: potential new therapy for ovarian clear cell adenocarcinoma.
    Ezawa S; Suzuki N; Ohie S; Higashiguchi A; Hosoi F; Kitazato K; Susumu N; Aoki D
    Gynecol Oncol; 2008 Mar; 108(3):627-31. PubMed ID: 18048092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of cell-cycle arrest and apoptosis by a novel retinobenzoic-acid derivative, TAC-101, in human pancreatic-cancer cells.
    Fujimoto K; Hosotani R; Doi R; Wada M; Lee JU; Koshiba T; Miyamoto Y; Tsuji S; Nakajima S; Imamura M
    Int J Cancer; 1999 May; 81(4):637-44. PubMed ID: 10225456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4- [3,5-bis(trimethylsilyl)benzamido] benzoic acid (TAC-101) induced fas expression and activated caspase-3 and -8 in a DLD-1 colon cancer cell line.
    Inoue Y; Nakayama Y; Sako T; Minagawa N; Abe Y; Nagato M; Kadowaki K; Katsuki T; Matsumoto K; Tsurudome Y; Shibao K; Hirata K; Nagata N
    In Vivo; 2007; 21(2):381-7. PubMed ID: 17436592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDP-Lys(L18), a lipophilic derivative of muramyl dipeptide, inhibits the metastasis of haematogenous and non-haematogenous tumours in mice.
    Yoo YC; Saiki I; Sato K; Azuma I
    Vaccine; 1994 Feb; 12(2):175-60. PubMed ID: 8147100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral administration of a Kampo (Japanese herbal) medicine Juzen-taiho-to inhibits liver metastasis of colon 26-L5 carcinoma cells.
    Ohnishi Y; Fujii H; Hayakawa Y; Sakukawa R; Yamaura T; Sakamoto T; Tsukada K; Fujimaki M; Nunome S; Komatsu Y; Saiki I
    Jpn J Cancer Res; 1998 Feb; 89(2):206-13. PubMed ID: 9548449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of E7010 on liver metastasis and life span of syngeneic C57BL/6 mice bearing orthotopically transplanted murine Colon 38 tumor.
    Funahashi Y; Koyanagi N; Kitoh K
    Cancer Chemother Pharmacol; 2001; 47(2):179-84. PubMed ID: 11269745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.